1.

Clinical spectrum and predictors of severity of dengue among children

2. Name:
3. Age:
4. General and systemic clinical manifestations of patients:

Fever and associated features Severe Non-severe

Fever
Highest recorded temperature
Duration of fever
Lethargy
Headache
Backache
Retroorbital pain
Joint manifestations
Hemorrhagic manifestation
Features of plasma leakage and
shock

5. Investigation profile of patients

Fever and associated features Severe Nonsevere

Increased hematocrit
Reduced hemoglobin level
Thrombocytopenia
Leucopenia
2. Platelet Count in Pediatric Patients with Dengue Fever Admitted in A
Tertiary Care Hospital in Bangladesh
1. Age
2. Gender
3. Mean platelet count
4. Having thrombocytopenia: Yes / No
5. Classification of dengue

6. Dengue Serology

7. Platelet count (mcL)

 3. Clinical and hematological profiles of children with Dengue Fever
1. Age
2. Gender
3. Comorbidities

4. NS1 Antigen (present)*

5. Anti-Dengue IgM antibody (present)*
6. Anti-Dengue IgG antibody (present)*
7. Types of infection

8. Clinical features of children with dengue at presentation

 Duration of fever (days)
 Duration of hospital stay (days)
 Symptoms
 Signs
9. Hematological profile of children
 Hematological profile of children
 Hematocrit (%)
 Hematocrit >48 (raised hematocrit)
 Leucocyte (x 103 cells/μL)
 Leucocyte <4 (leucopenia)
 Platelet (x 103 cells/μL)
 Platelet <150 (thrombocytopenia)
4. Prevalence of Dengue and Dengue Hemorrhagic Fever among Children in
Bangladesh

1. Name:
2. Age:
3. Gender:
4. Clinical manifestations of Dengue fever
 Fever
a) Yes b) No
 Nausea/vomiting
a) Yes b) No
 Headache,
 Diarrhoea
 Myalgia
 Abdominal pain,
5. The total duration of the fever…………………Days

6. Haemorrhagic manifestations
 Petechiae
 Epistaxis
 Gum bleeding
 Haematemesis
 Vaginal bleeding
 Bleeding >2 sites
 5. Impact of Covid-19 on pulmonary Dysfunction of children
1. Age
2. Gender
3. RT PCR TEST result

4.
6. Congenital Heart Disease & its associated factors in Bangladesh
1. Age
2. Gender
3. comorbidity.
4. Maternal characteristics of study group

Variable Code (Please tic)

Birth weight (g) 1
<2,500 2
2500-<3000 3
3000-<3500 4
3500-<4000 5
>4000 6

Gestational age (weeks)

<37
37-38
38
39-40
>40
Prenatal infection
1, Yes
2, No
Prenatal contact with toxic substances
Yes
No
Prenatal medication use
Yes
No
Gestational hypertension
Yes
No
Gestational diabetes
Yes
No
Prenatal anemia
Yes
No
Smoking
Yes
No
Family history of CHD

Family History
History of mother with CHD
Yes
No
History of father with CHD
Yes
No

5. Prevalence of CHD type

Prevalence of CHD type

Atrial septal defect
Ventricular septal defect
Patent foramen ovale
Patent ductus arteriosus
Pulmonary stenosis